Abstracts
Showing 851 abstracts.
Citation
Denise Gaughan, M.P.H., Steven Gortmaker, Ph.D., George Seage, III, Sc.D., M.P.H. The Prevalence of Pain in Pediatric HIV/AIDS and its Effect on Quality of Life as Reported by Participants in the Pediatric Late Outcomes Study (PACTG 219).Citation
James M. Oleske, M.D., Harland S. Winter, M.D., Ross E. McKinney, Jr., M.D., Michael Hughes, Ph.D., Christine Powell, M.A., Carol Elgie, B.S., Anne Fresia, B.A., James McNamara, M.D., John ( Jack ) Moye, Jr., M.D. Prospective Monitoring of Perinatal HIV Transmission and Infant Mortality in Pediatric AIDS Clinical Trials Group PACTG Protocol 247: How Low Can We Go?.Citation
Wayne M. Dankner, M.D. Phase II/III, Randomized, Double-Blind Trial to Compare Atovaquone Plus Azithromycin (AT/AZ) to Trimethoprim-Sulfamethoxazole (TMP-SMX) in the Prevention of Multiple Opportunistic Pathogen Infections (MOPPS) in HIV-Infected Children.Citation
Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., Chris Weedy, M.S.W., James M. Oleske, M.D. Providing supportive care and promoting quality of life for HIV-infected children in a multi-centerd clinical trials network.Citation
Mark W. Kline, M.D., Courtney V. Fletcher, Pharm.D., Jane C. Lindsey, Sc.D. A randomized trial of combination therapy with saquinavir soft gelatin capsules (SQV) in HIV-infected children.Citation
Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Carmen D. Zorrilla, M.D., Edward P. Acosta, Pharm.D., Russell B. Van Dyke, M.D., Jane Pitt, M.D., Michael Hughes, Ph.D., Sharon Huang, M.S., Barbara E. Heckman, B.S., Shiara Melissa Ortiz-Pujols, B.A., Elizabeth (Betsy) Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P. Adherence to Highly Active antiretroviral Therapy During Pregnancy and Postpartum in a Phase I Study of Saquinavir-SGC (SQV) with Ritonavir (RTV) in Combination with Zidovudine (ZDV) and Lamivudine (3TC): Preliminary Results of PACTG 386.Citation
Yvonne J. Bryson, M.D., Ruth E. Dickover, Ph.D., Alice M. Stek, M.D., Mark Mirochnick, M.D., James D. Connor, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Heather D. Watts, M.D., Sharon Huang, M.S., Michael Hughes, Ph.D., B. Cunnington, Lynette Purdue, Pharm.D., Diane W. Wara, M.D., Yetemegnu Asfaw, B.S., Elizabeth (Betsy) Smith, M.D. PACTG 353: Combined Treatment with HAART (NFV/3TC/ZDV) Increases Thymic Output in HIV Infected Pregnant Women.Citation
Elizabeth (Betsy) J. McFarland, M.D., William Borkowsky, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Paul Harding, M.S., Lisa M. Frenkel, M.D., Bobbie L. Graham, B.S., Edmund Capparelli, Pharm.D., Edmund Capparelli, Pharm.D., Shirley Jankelevich, M.D., John ( Jack ) Moye, Jr., M.D., Ram Yogev, M.D. Increases in HIV-specific CD4+ and CD8+ t cell-mediated responses in children chronically infected with HIV-1 undergoing structured treatment interruption (STI).Study
P1015